X
Record #28884

ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)

Publisher
Elsevier
Original paper date
Dec 13, 2020
Institution
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China · Department II of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China · Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China · Department of Respiratory Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China · The Third Department of Chemotherapy, Weihai Municipal Hospital, Weihai, China · Department of Oncology, Linyi Cancer Hospital, Linyi, China · Medical Oncology, Chinese People's Liberation Army General Hospital, Beijing, China · Department I of Thoracic Oncology, Peking University Cancer Hospital & Institute, Beijing, China · Department of Oncology, Beijing Chao-Yang Hospital, Beijing, China · Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China · Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou Medical University, Xuzhou, China · Department of Oncology, Shanghai Pulmonary Hospital, Shanghai, China · Medical Oncology, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin, China · Cancer Hospital, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Teaching Hospital of Fujian Medical University, Department of Medical Oncology, Xiamen, China · Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China · Oncology Department, Affiliated Hospital of Jining Medical University, Jining, China · Department of Respiratory Medicine, Peking Union Medical College Hospital, Beijing, China · Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China · Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
Open access
No
Broad categories
(HSC) Medicine - Oncology(HSC) Medicine - Pharmacology(HSC) Medicine - Pulmonology
Citation lifecycle

How this paper is being cited

Pre-retraction
0
Same day
0
Post-retraction
5
% post-retraction
100.0%
~0.0 citations/yr before retraction · ~0.9 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse